核医影像设备市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 产业预测，2024-2031 年

2022年全球核医影像设备市场规模为30.2亿美元，从2023年的32.5亿美元成长到2031年的57.5亿美元，在预测期间（2024-2031年）预计将以复合年增长率成长。年为7.41%）。

由于技术进步和对提高诊断准确性的日益关注，核医学影像设备市场预计将显着成长。包括 PET/MRI 和 PET/CT 在内的混合成像系统等创新增强了功能，可以更准确地可视化和诊断各种放射性状况。随着慢性病的流行和医疗保健支出的增加，对这些先进诊断影像工具的需求不断增加。然而，市场面临着监管障碍和与使用放射性材料相关的高成本等挑战。儘管存在这些障碍，但充满希望的成长机会正在出现，特别是随着监管机构简化新技术的核准流程以及医疗保健行业专注于改善患者体验。随着放射性药物开发的进步以及人们对及时准确诊断重要性的日益认识，核医学影像市场预计在未来几年将显着成长。总体而言，创新成像解决方案和改进的以患者为中心的方法的整合预计将塑造医疗保健这一重要领域的未来。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价格分析
• 价值链分析
• 供应链分析

核子医学影像设备市场：依产品分类

• 市场概况
• 单光子发射电脑断层扫描 (SPECT) 影像系统
  • 混合SPECT 影像系统
  • 独立 SPECT 影像系统
• 混合PET成像系统
• 平面闪烁闪烁图术成像系统

核子医学影像设备市场：依应用分类

• 市场概况
• 瘤
• 心臟病
• 神经
• 其他用途

核子医学影像设备市场：依最终用户分类

• 市场概况
• 医院
• 形像中心
• 学术研究中心
• 其他最终用户

核子医学影像设备市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Siemens AG
• General Electric
• Koninklijke Philips NV
• TTG Imaging Solutions
• Neusoft Corporation
• Canon Inc.
• Surgiceye GmbH
• Bozlu Holding
• CMR Naviscan Corporation
• Mediso Ltd.
• Shimadzu Corporation
• Revvity Inc
• Rigaku
• MR Solutions Ltd.
• Agfa-Gevaert NV
• Medtronic plc
• Bracco Group
• Cubresa Inc.
• Jubilant Radiopharma
• South African Nuclear Energy Corporation（Necsa）

Global Nuclear Imaging Equipment Market size was valued at USD 3.02 billion in 2022 and is poised to grow from USD 3.25 billion in 2023 to USD 5.75 billion by 2031, growing at a CAGR of 7.41% during the forecast period (2024-2031).

The nuclear imaging equipment market is poised for significant growth, driven by advancements in technology and an increased focus on improving diagnostic accuracy. Innovations such as hybrid imaging systems, including PET/MRI and PET/CT, are enhancing functionality, allowing for more precise visualization and diagnosis of various medical conditions using radioactive materials. As chronic diseases become more prevalent and healthcare expenditures rise, the demand for these sophisticated imaging tools is on the rise. However, the market faces challenges, including regulatory hurdles and the high costs associated with the use of radioactive substances. Despite these obstacles, there are promising opportunities for growth, particularly as regulatory bodies simplify the approval process for new technologies and as the healthcare sector places greater emphasis on enhancing patient experience. With ongoing developments in radiopharmaceuticals and an increasing recognition of the importance of timely and accurate diagnostics, the nuclear imaging equipment market is set to experience substantial advancements in the coming years. Overall, the integration of innovative imaging solutions and improved patient-centric approaches is expected to shape the future of this vital sector in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Equipment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Equipment Market Segmental Analysis

Global Nuclear Imaging Equipment Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) Imaging Systems (Hybrid SPECT Imaging Systems, Standalone SPECT Imaging Systems), Hybrid PET Imaging Systems, Planar Scintigraphy Imaging Systems. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Other Applications. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic & Research Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market is significantly driven by the emergence of hybrid systems like PET/MRI and PET/CT, which seamlessly integrate various imaging modalities to deliver unparalleled precision and comprehensive diagnostic information. This convergence of technologies not only improves imaging accuracy but also broadens the scope of conditions that can be diagnosed through nuclear imaging, thereby elevating awareness and clinical significance among healthcare providers and patients alike. Furthermore, advancements in radiopharmaceuticals have refined the imaging process, enhancing the efficacy and reliability of diagnoses, thus contributing robustly to the growth trajectory of the nuclear imaging market.

Restraints in the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market faces significant restraints primarily due to the intricate and constrained development of radiopharmaceuticals essential for imaging procedures. Challenges related to production capacity and supply chain logistics can lead to critical shortages of these vital substances, hindering their availability in the market. Additionally, the inherent short half-lives of most radiopharmaceuticals necessitate rapid manufacturing and distribution, compounding the difficulty in meeting demand. Such complexities in production and quality control processes not only limit the supply of nuclear imaging agents but also pose substantial delays, ultimately restricting the overall growth potential of the nuclear imaging equipment sector.

Market Trends of the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market is witnessing a notable trend driven by advancements in radiopharmaceuticals that enhance diagnostic capabilities across various diseases. Innovations in novel tracers are facilitating the detection of complex conditions such as cancer, cardiovascular diseases, and neurological disorders. Moreover, the rise of theragnostic approaches-integrating targeted therapy with diagnostic imaging-is gaining traction, particularly in oncology, allowing for personalized treatment plans. This convergence of diagnostics and therapeutics is expected to augment market growth, as healthcare providers increasingly adopt these advanced technologies to improve patient outcomes and streamline treatment processes, ultimately reshaping the landscape of medical imaging.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis

Nuclear Imaging Equipment Market, By Product

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT) Imaging Systems
  • Hybrid SPECT Imaging Systems
  • Standalone SPECT Imaging Systems
• Hybrid PET Imaging Systems
• Planar Scintigraphy Imaging Systems

Nuclear Imaging Equipment Market, By Application

• Market Overview
• Oncology
• Cardiology
• Neurology
• Other Applications

Nuclear Imaging Equipment Market, By End User

• Market Overview
• Hospitals
• Imaging Centers
• Academic & Research Centers
• Other End Users

Nuclear Imaging Equipment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTG Imaging Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgiceye GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bozlu Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rigaku
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert N.V
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Radiopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• South African Nuclear Energy Corporation (Necsa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments